Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

JAK2, MPL, and CALR mutations in Chinese Han patients with essential thrombocythemia.

Hematology (Amsterdam, Netherlands) - 1 Apr 2017

Wang Jing, Zhang Biao, Chen Bing, Zhou Rong-Fu, Zhang Qi-Guo, Li Juan, Yang Yong-Gong, Zhou Min, Shao Xiao-Yan, Xu Yong, Xu Xi-Hui, Ouyang Jian, Xu Jingyan, Ye Qing

Abstract excerpt

BACKGROUND: Mutations in Janus kinase 2 (JAK2), myeloproliferative leukemia (MPL), and CALR are highly relevant to Philadelphia chromosome (Ph)-negative myeloproliferative neoplasms. METHODS: Assessing the prevalence of molecular mutations in Chinese Han patients with essential thrombocythemia (ET), and correlating their mutational profile with disease characteristics/phenotype. RESULTS: Of the 110 subjects...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Asian People

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Calreticulin

Share to DNA Mutational Analysis

Share to Janus Kinase 2

Share to Receptors, Thrombopoietin

Share to Thrombocythemia, Essential

Source

Identifiers

PMID: 27875935
DOI: 10.1080/10245332.2016.1252003

Genes

CALR
JAK2
MPL

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

JAK2, MPL, and CALR mutations in Chinese Han patients with essential thrombocythemia.PMID 27875935Read ↗

Frequency and allele burden of CALR mutations in Chinese with essential thrombocythemia and primary myelofibrosis without JAK2(V617F) or MPL mutations.Semantic proximity Read ↗

The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms.Semantic proximity Read ↗

Frequencies, Laboratory Features, and Granulocyte Activation in Chinese Patients with CALR-Mutated Myeloproliferative Neoplasms.Semantic proximity Read ↗

CALR mutations screening in wild type JAK2(V617F) and MPL(W515K/L) Brazilian myeloproliferative neoplasm patients.Semantic proximity Read ↗

CALR, JAK2, and MPL mutation profiles in patients with four different subtypes of myeloproliferative neoplasms: primary myelofibrosis, essential thrombocythemia, polycythemia vera, and myeloproliferative neoplasm, unclassifiable.Semantic proximity Read ↗

Detecting Multiple Driver Mutations in a Patient with Essential Thrombocythemia.Semantic proximity Read ↗

Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms.Semantic proximity Read ↗

JAK2, CALR, and MPL mutation spectrum in Japanese patients with myeloproliferative neoplasmsSemantic proximity Read ↗

JAK2 or CALR Mutations Status and Bone Marrow Histology in Patients with Essential Thrombocythemia in ChineseSemantic proximity Read ↗

Study of CALR, MPL, and c-kit Gene Mutations in Thai Patients with JAK2 V617F Negative Myeloproliferative Neoplasms.Semantic proximity Read ↗

JAK2 V617F, MPL, and CALR Mutations in Korean Patients with Essential Thrombocythemia and Primary Myelofibrosis.Semantic proximity Read ↗

Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.